Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

INTRODUCTION: Iron deficiency anemia (IDA) is common in patients with gastrointestinal (GI) disorders and can adversely affect quality of life. Oral iron is poorly tolerated in many patients with GI disorders. Ferumoxytol is approved for the intravenous treatment of IDA in patients with chronic kidn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Gastroenterol
Main Authors: Ford, David C, Dahl, Naomi V, Strauss, William E, Barish, Charles F, Hetzel, David J, Bernard, Kristine, Li, Zhu, Allen, Lee F
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946860/
https://ncbi.nlm.nih.gov/pubmed/27468245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S101473
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados